相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305
Cinzia Giordano et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Expression of the K303R Estrogen Receptor-α Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway
Ines Barone et al.
CANCER RESEARCH (2009)
Phosphorylation of the oestrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer
C. Holm et al.
JOURNAL OF PATHOLOGY (2009)
Akt phosphorylation of La regulates specific mRNA translation in glial progenitors
F. Brenet et al.
ONCOGENE (2009)
A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions
A. Deeb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity
Robin Tharakan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Regulation of estrogen receptor α by the SET7 lysine methyltransferase
Krithika Subramanian et al.
MOLECULAR CELL (2008)
Development of HER2-antagonistic peptides as novel anti-breast cancer drugs by in silico methods
Hiroo Nakajima et al.
BREAST CANCER (2008)
Dynein light chain 1 peptide inhibits human immunodeficiency virus infection in eukaryotic cells
Danielle Renee Fontenot et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor α tyrosine-phosphorylated peptide
Lilian Varricchio et al.
MOLECULAR CANCER RESEARCH (2007)
Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity
Suresh K. Rayala et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
Association between the estrogen receptor α A908G mutation and outcomes in invasive breast cancer
Matthew H. Herynk et al.
CLINICAL CANCER RESEARCH (2007)
The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor
Annemie Haelens et al.
CANCER RESEARCH (2007)
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Deepali Sachdev et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity
Varsha S. Likhite et al.
MOLECULAR ENDOCRINOLOGY (2006)
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells
Matthew H. Herynk et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Post-translational modifications of steroid receptors
H. Faus et al.
BIOMEDICINE & PHARMACOTHERAPY (2006)
Acetylation of estrogen receptor α by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor
Mi Young Kim et al.
MOLECULAR ENDOCRINOLOGY (2006)
Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer
Andrea Romano et al.
GYNECOLOGIC ONCOLOGY (2006)
P21-activated kinase 1 regulation of estrogen receptor-α activation involves serine 305 activation linked with serine 118 phosphorylation
SK Rayala et al.
CANCER RESEARCH (2006)
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model
CM Staka et al.
ENDOCRINE-RELATED CANCER (2005)
Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole
D Jelovac et al.
CANCER RESEARCH (2005)
Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
RJ Santen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation
GJ Sabnis et al.
CANCER RESEARCH (2005)
The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study
K Conway et al.
BREAST CANCER RESEARCH (2005)
Insulin-like growth factor ligands, receptors, and binding proteins in cancer
E Foulstone et al.
JOURNAL OF PATHOLOGY (2005)
The role of Shc and insulin-like qrowth factor 1 receptor in mediating the translocation of estrogen receptor a to the plasma membrane
RX Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells
D Sachdev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphorylation of estrogen receptor a blocks its acetylation and regulates estrogen sensitivity
Y Cui et al.
CANCER RESEARCH (2004)
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk
IU Agoulnik et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
R Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer
R Michalides et al.
CANCER CELL (2004)
Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro
H Ksiezak-Reding et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)
Enhanced estrogen receptor (ER) α, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation
LA Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
